We Support New Ideas
Our Mission: To Fund New Ideas at Their Inception
The Society’s independently judged, peer-reviewed research grants are highly valued by researchers and considered important and prestigious within the scientific community.
The Society has funded research projects by most of Canada’s top glaucoma researchers – doctors and scientists interested in finding new treatments and in preventing blindness from glaucoma. These highly respected researchers are recognized across Canada and internationally.
Their research includes:
- seeking to protect good nerve cells in the eye and repair damaged ones
- searching for genes related to glaucoma
- improving blood flow to the eye, and
- making glaucoma surgery easier for the patient.
Glaucoma Research Society of Canada grants $315,040 to 16 Research Projects in 2022:
- Krembil Research Institute/ Donald K. Johnson Institute, Toronto, ON
SKI-1 inhibition promotes optic nerve regeneration in an animal model for Glaucoma.
Dr. Philippe Monnier - University of Toronto, Toronto, ON
How many patients with glaucoma were identified from routine eye exams by optometrists?
Dr. Yaping Jin, Dr. Yvonne Buys - University of Toronto, Toronto, ON
Cytokine profiles in different stages of primary open angle glaucoma
Dr. Ellen Zhou, Dr. Jeremy Sivak, Dr. Irfan Kherani, Dr. David Mathew & Dr. Matthew Schlenker - Dalhousie University, Halifax, NS
Neuroprotective Effects of Lithium in a Model of Experimental Glaucoma
Dr. Balwantray Chauhan, Dr. Tomas Hajek - Krembil Research Institute/ Donald K. Johnson Institute, Toronto, ON
Advanced visual telerehabilitation: Home-based audiovisual stimulation protocol with virtual reality in glaucoma patients – a pilot study.
Dr. Michael Reber, Dr. Monica Daibert-Nido - McMaster University, Hamilton, ON
Eye Patient Adherence and Compliance (EYE-PAC) Intervention Program: Improving glaucoma adherence and compliance among high-risk patients with pilot multi–interventional program
Dr. Enitan Sogbesan - Dalhousie University, Halifax, NS
Risk of Angle Closure Glaucoma and Posterior Subcapsular Cataract with Methylphenidate Use for Attention Deficit Hyperactivity Disorder
Dr. Brennan Eadie, Dr. Mahyar Etminan, Dr. Bonnie He, Dr. Rami Darwich - University of Toronto, Toronto, ON
Can Corneal Biomechanics Predict Glaucoma Surgery Outcomes?
Dr. Ike Ahmed, Dr. Matt B. Schlenker, Dr. Irfan Kherani, Dr. James J. Armstrong - McGill University Health Centre Research Institute, Montreal, QC
Assessing Possible Photoreceptor Loss in Primary Open-Angle Glaucoma by OCT and Histology
Dr. Miguel N Burnier Jr, Dr. Nabil Saheb - Unity Health, University of Toronto, Toronto, ON
Do Cardiac Hormones Play a Role in Glaucoma?
Dr. Neeru Gupta, Dr. Yeni Yϋcel - University of British Columbia, Vancouver, BC
Risk of angle closure glaucoma with bisphosphonates in osteoporosis patients
Dr. Mahyar Etminan, Dr. Bonnie He, Dr. Rami Darwich, Dr. Brennan Eadie - University of Calgary, Calgary, AB
Adaptation of Accessible Virtual Reality Technologies for Surgical Training in Glaucoma
Dr. Patrick Gooi, Dr. Derek Waldner, Dr. Abdullah Sarhan - University of Toronto, Toronto, ON
Intraocular Pressure Comparisons with Icare HOME versus iCare IC200
Dr. Jenn Qian, Dr. Matt Schlenker, Dr. Irfan Kherani - Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON
Impact of Breathing Exercises and Meditation in Reducing Stress in Glaucoma Patients During COVID-19 Pandemic: An Electronic Pilot Feasibility Study
Dr. Monali Malvankar, Dr. Cindy M.L Hutnik - RENEWAL: Université Laval, Quebec City, QC
Comparison of Laser Diode Parameters
Dr. Andrew Toren, Dr. Béatrice Des Marchais, Dr. Catherine Baril, Dr. Caroline Lajoie, Dr. Annie Goyette - RENEWAL: Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON
Impact of Meditation on Reducing Stress in Glaucoma Patients During COVID-19 Pandemic: An Electronic Pilot Feasibility Study
Dr. Monali Malvankar & Dr. Cindy Hutnik
Funds Raised Goes to Researchers Throughout Canada
The Glaucoma Research Society of Canada is the only Canadian non-profit organization solely dedicated to funding glaucoma research. Since 1989, it has raised more than five million dollars in support of 247 research projects. The Society funds 10 to 15% of all independent glaucoma research in Canada.
Sound governance, a volunteer board, and low administration costs ensure that as much funds raised by the Society go directly to Canadian researchers.
Registered charity information returns including detailed financial information are available online at the federal government’s Charities Directorate (part of the Canada Revenue Agency). The Society’s Charitable Donation Registration Number is 88917 8695 RR0001.
Dr. Cindy Hutnik and her team of researchers with Dr. Trope at GRSC’s 2020 Annual Supporters’ Meeting
Your donations have funded numerous scientists who have gained international respect and reputations in advancing research into glaucoma.
The next decade should see some important breakthroughs including methods to maintain and possibly even repair damaged optic nerves in glaucoma.
Your support is essential to continue this valuable and much needed research.
Alexandre Ball and his team of researchers, 2009
Research Grant Applications
Researchers into glaucoma from across Canada apply annually for funding. Independent peers review the applications under the guidance of the Scientific Advisory Committee of renowned ophthalmologists and scientists from across the country. The Committee makes funding recommendations to the Society’s Board of Directors.
Applying for a Grant
Call for Submissions
Terms and Conditions
Grant Application Form (doc)